Advanced search
Publication Cover
Scandinavian Journal of Clinical and Laboratory Investigation Volume 57, 1997 - Issue 3
Submit an article Journal homepage
57
Views
24
CrossRef citations to date
0
Altmetric
Miscellaneous Article

Histamine in cancer immunotherapy

K. Hellstrand Departments of Virology, Haematology and Surgery, Sahlgren's University Hospital, Göteborg, Sweden
,
S. Hermodsson Departments of Virology, Haematology and Surgery, Sahlgren's University Hospital, Göteborg, Sweden
,
M. Brune Departments of Virology, Haematology and Surgery, Sahlgren's University Hospital, Göteborg, Sweden
,
P. Naredi Departments of Virology, Haematology and Surgery, Sahlgren's University Hospital, Göteborg, Sweden
,
J. Carneskog Departments of Virology, Haematology and Surgery, Sahlgren's University Hospital, Göteborg, Sweden
&
U.-H. Mellqvist Departments of Virology, Haematology and Surgery, Sahlgren's University Hospital, Göteborg, SwedenView further author information
Pages 193-202 | Published online: 05 Aug 2009

Citations (24)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Kristoffer Hellstrand, Mats Brune, Peter Naredi, Ulf-Henrik Mellqvist, Markus Hansson, Kurt R. Gehlsen & Svante Hermodsson. (2000) Histamine: A Novel Approach to Cancer Immunotherapy. Cancer Investigation 18:4, pages 347-355.
Read now
Kristoffer Hellstrand, Svante Hermodsson, Peter Naredi, Ulf-Henrik Mellqvist & Mats Brune. (1998) Histamine and Cytokine Therapy: Paper presented at the annual meeting of the Swedish Oncology Society, Stockholm, 1997. Acta Oncologica 37:4, pages 347-353.
Read now

Articles from other publishers (22)

María de la Paz Sarasola, Mónica A. Táquez Delgado, Melisa B. Nicoud & Vanina A. Medina. (2021) Histamine in cancer immunology and immunotherapy. Current status and new perspectives. Pharmacology Research & Perspectives 9:5.
Crossref
Elena L. Paley. (2021) Towards Understanding COVID-19: Molecular Insights, Co-infections, Associated Disorders, and Aging. Journal of Alzheimer's Disease Reports 5:1, pages 571-600.
Crossref
Jake N. Lichterman & Sangeetha M. Reddy. (2021) Mast Cells: A New Frontier for Cancer Immunotherapy. Cells 10:6, pages 1270.
Crossref
Sharon A. Oldford & Jean S. Marshall. (2015) Mast cells as targets for immunotherapy of solid tumors. Molecular Immunology 63:1, pages 113-124.
Crossref
Sharon A. Oldford & Jean S. Marshall. 2013. The Tumor Immunoenvironment. The Tumor Immunoenvironment 479 509 .
Jolanta B PerzAnthony D Ho. (2008) Histamine dihydrochloride for the treatment of acute myeloid leukemia, malignant melanoma and renal cell carcinoma. Future Oncology 4:2, pages 169-177.
Crossref
Teresa Zak-Nejmark, Renata Jankowska, Ewa Passowicz-Muszynska, Jozef Malolepszy, Marek Marciniak, Anna Jonkisz & Maria Kraus-Filarska. (2004) Skin reactivity to histamine and expression of histamine receptors mRNA in lymphocytes of healthy subjects and non-small-cell lung cancer patients before and after surgery. Lung Cancer 45:1, pages 31-38.
Crossref
Steven J O'Day, Sanjiv S Agarwala, Peter Naredi, Carrie L Kass, Kurt R Gehlsen & John Glaspy. (2003) Treatment with histamine dihydrochloride and interleukin-2 in patients with advanced metastatic malignant melanoma. Melanoma Research 13:3, pages 307-311.
Crossref
Zsuzsa Darvas, Eiko Sakurai, Hubert G Schwelberger, Hargita Hegyesi, Elena Rivera, Hiroshi Othsu, Takehiko Watanabe, Eva Pállinger & Andras Falus. (2003) Autonomous histamine metabolism in human melanoma cells. Melanoma Research 13:3, pages 239-246.
Crossref
Wolfram E Samlowski, Ryan Petersen, Salvatore Cuzzocrea, Heather Macarthur, Damali Burton, John R McGregor & Daniela Salvemini. (2003) A nonpeptidyl mimic of superoxide dismutase, M40403, inhibits dose-limiting hypotension associated with interleukin-2 and increases its antitumor effects. Nature Medicine 9:6, pages 750-755.
Crossref
Frank Alexander Hamill. (2016) Research Briefings. Integrative Cancer Therapies 2:1, pages 91-93.
Crossref
Maurizio Previati, Andrea Raspadori, Lucia Bertolaso, Alina Parmeggiani, Debora Bindini, Cristina Vitali, Irene Lanzoni, Elisa Corbacella, Massimo Saviano, Francesco Fagioli, Gabriella Blo & Silvano Capitani. (2002) Determination of histamine in the whole blood of colon cancer patients. Journal of Chromatography B 780:2, pages 331-339.
Crossref
Mark Middleton, Mark Sarno, Sanjiv S. Agarwala, John Glaspy, Aziz Laurent, Kelly McMasters, Peter Naredi, Steven O'Day, Eric Whitman, Sarah Danson, Rebecca Cosford & Kurt Gehlsen. (2013) Pharmacokinetics of Histamine Dihydrochloride in Healthy Volunteers and Cancer Patients: Implications for Combined Immunotherapy with Interleukin‐2. The Journal of Clinical Pharmacology 42:7, pages 774-781.
Crossref
John A Glaspy. (2002) Therapeutic options in the management of renal cell carcinoma. Seminars in Oncology 29:3, pages 41-46.
Crossref
Peter Naredi. (2002) Histamine as an adjunct to immunotherapy. Seminars in Oncology 29:3, pages 31-34.
Crossref
Sanjiv S. AgarwalaJohn GlaspySteven J. O’DayMalcolm MitchellJohn GutheilEric WhitmanRene GonzalezEvan HershLynn FeunRobert BeltFrank MeyskensKristoffer HellstrandDiana WoodJohn M. KirkwoodKurt R. GehlsenPeter Naredi. (2002) Results From a Randomized Phase III Study Comparing Combined Treatment With Histamine Dihydrochloride Plus Interleukin-2 Versus Interleukin-2 Alone in Patients With Metastatic Melanoma. Journal of Clinical Oncology 20:1, pages 125-133.
Crossref
K Hellstrand, M Brune, C Dahlgren, M Hansson, S Hermodsson, P Lindnér, U-H Mellqvist & P Naredi. (2000) Alleviating oxidative stress in cancer immunotherapy: a role for histamine?. Medical Oncology 17:4, pages 258-269.
Crossref
Ian D Davis. (2000) An overview of cancer immunotherapy. Immunology and Cell Biology 78:3, pages 179-195.
Crossref
Kristoffer Hellstrand, Markus Hansson & Svante Hermodsson. (2000) Adjuvant histamine in cancer immunotherapy. Seminars in Cancer Biology 10:1, pages 29-39.
Crossref
Nina Grosman. (1999) Effect of the anti-neoplastic agents edelfosine (ET-18-OCH3), ilmofosine (BM 41.440) and the hexadecylphosphocholine analogues D-20133 and D-21266 on histamine release from isolated rat mast cells. Immunopharmacology 44:3, pages 211-221.
Crossref
Sofia Eleftheriou, Dimitrios Gatos, Antonis Panagopoulos, Stephanos Stathopoulos & Kleomenis Barlos. (1999) Attachment of histidine, histamine and urocanic acid to resins of the trityl-type. Tetrahedron Letters 40:14, pages 2825-2828.
Crossref
P. Hersey. (1999) Impediments to Successful Immunotherapy. Pharmacology & Therapeutics 81:2, pages 111-119.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.